أحدث 30 ورقة عربية منشورة عن المضادات الحيوية

– تاريخ التحديث: 14 رجب 1446 – 14  يناير 2025.
– المصدر: (Web of Science (Clarivate.
– نوع الأوراق: ARTICLE & REVIEW
– تغطي هذه المجموعة من الأوراق مواضيع متعلقة بمقاومة المضادات الحيوية واستخدامها، مع التركيز على التقييمات الجينومية، وبرامج الإشراف الدوائي، ودراسة آليات مقاومة البكتيريا مثل الكاربينيمات والبيتا-لاكتاميز. كما تسلط الضوء على حلول مبتكرة مثل أنظمة توصيل الأدوية بتقنيات النانو، التشخيص بالعقاقير الإشعاعية، ومنظور الصحة الواحدة لمعالجة مقاومة الميكروبات وتحسين الرعاية الصحية.

أحدث ثلاث مراجعات عالمية

Effectiveness of macrolides as add-on therapy to beta-lactams in community-acquired pneumonia: A meta-analysis of randomized controlled trials
Prizao, VM; Martins, OC; Morais, BADD; Mendes, BX; Defante, MLR; Souza, MD
JAN 2025 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 81 (1) pp: 83-91

>

Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation
Darlow, CA; Hope, W; Dubey, V
Nov 11 2024 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

>

Bacterial Secondary Metabolites Embedded in Producer Cell Membranes and Antibiotics Targeting Their Biosynthesis
Xia, Z; Xiang, H; Shi, YM
Nov 8 2024 | CHEMMEDCHEM

.

أحدث ثلاثين ورقة عربية

1. Point prevalence survey of antibiotics use among hospitalised neonates and children in Saudi Arabia: findings and implications
   Alosaimi, HM; Alshammari, MK; Fetyani, MM; Allehidan, MS; Almalki, TJ; Hussain, KH; Hussain, HH; Althobaiti, MD; Alharbi, AS; …; Alamro, RA; Najmi, A
   DEC 31 2024 | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE 17 (1)

2. Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit
   Al-Sulaiti, FK; Alkhiyami, D; Elmekaty, EZI; Awaisu, A; Kheir, N; El-Zubair, A; Al-Sulaiti, HK
   DEC 31 2024 | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE 17 (1)

3. The cost associated with the development of the antimicrobial stewardship program in the adult general medicine setting in Qatar
   Abushanab, D; AL-Marridi, W; Al Hail, M; Rouf, PVA; ElKassem, W; Thomas, B; Alsoub, H; Ademi, Z; Hanssens, Y; El Enany, R; Al-Badriyeh, D
   DEC 31 2024 | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE 17 (1)

4. Healthcare commissioners’ experience with antibiotic resistance during the COVID-19 pandemic in Saudi Arabia: a qualitative study
   Al Sulayyim, HJ; Ismail, R; Al Hamid, A; Ghafar, NA
   DEC 31 2024 | JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE 17 (1)

5. Characterization of blaNDM in two Escherichia coli ST1193 clinical isolates in the Gulf region
   Tsui, CKM; Ben Abid, F; McElheny, CL; Hamed, MM; Perez-Lopez, A; Omrani, AS; Doi, Y
   NOV 6 2024 | JAC-ANTIMICROBIAL RESISTANCE 6 (6)

6. Clarithromycin-tailored cubosome: A sustained release oral nano platform for evaluating antibacterial, anti-biofilm, anti-inflammatory, anti-liver cancer, biocompatibility, ex-vivo and in-vivo studies
   Abdullah, HD; Kamal, I; Sabry, SA; Abd Elghany, M; Ramadan, A
   DEC 25 2024 | INTERNATIONAL JOURNAL OF PHARMACEUTICS 667

7. Investigating an Outbreak of Extensively Drug-Resistant Acinetobacter baumannii in a Tertiary Healthcare Centre in Lebanon Using Next-Generation Sequencing
   Darwiche, FI; Hussein, HM; Harb, SB; Nahhal, S; Kurdi, A; Sleiman, A; Hamadeh, L; Barada, S; Gerges, JR; Araj, GF; Zahreddine, NK; Ibrahim, A; …; Abou Fayad, AG
   NOV 2024 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 64 (5)

8. Enterobacterales Producing ESBLs and AmpC in Fresh Vegetables from Tebessa City, Algeria
   Amra, A; Debabza, M; Dziri, R; Mechai, A; Ouzari, HI; Klibi, N
   NOV 1 2024 | MICROBIAL DRUG RESISTANCE 30 (11) pp: 458-467

9. Prevalence of carbapenem-resistant Enterobacterales (CRE) in Saudi Arabia: A systematic review and meta-analysis
   Alshehri, AA; Irekeola, AA
   NOV 2024 | SAUDI PHARMACEUTICAL JOURNAL 32 (11)

10. Imipenem-Cilastatin-Induced Seizures: A Case Report
    Aloui, G; Ben Houria, B; Yousfi, MA
    OCT 8 2024 | CURRENT DRUG SAFETY

11. Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases
    Le Terrier, C; Mlynarcik, P; Sadek, M; Nordmann, P; Poirel, L
    NOV 6 2024 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 68 (11)

12. A Systematic Review and Comprehensive Analysis of mcr Gene Prevalence in Bacterial Isolates in Arab Countries
    Bakleh, MZ; Kohailan, M; Marwan, M; Sulaiman, AA
    OCT 2024 | ANTIBIOTICS-BASEL 13 (10)

13. The Impact of Clinical Pharmacist-Driven Weekend Antimicrobial Stewardship Coverage at a Quaternary Hospital
    Elrefaei, H; El Nekidy, WS; Nasef, R; Motasem, M; Mkarim, Y; Al Quteimat, O; Hisham, M; Ismail, R; Abidi, E; Afif, C; El Lababidi, R
    OCT 2024 | ANTIBIOTICS-BASEL 13 (10)

14. Radiosynthesis and Preclinical Evaluation of [99mTc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
    Saleem, SM; Jabbar, T; Imran, MB; Noureen, A; Sherazi, TA; Afzal, MS; Nawaz, HZR; Ramadan, MF; Alkahtani, AM; Alsuwat, MA; Almubarak, HA; Momenah, MA; Naqvi, SAR
    OCT 2024 | PHARMACEUTICALS 17 (10)

15. Insights into the Rising Threat of Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa Epidemic Infections in Eastern Europe: A Systematic Literature Review
    Piotrowski, M; Alekseeva, I; Arnet, U; Yücel, E
    OCT 2024 | ANTIBIOTICS-BASEL 13 (10)

16. Efficacy of Ciprofloxacin in Treating Gram-Negative Infections: Does Obesity Matter?
    Alotaibi, S; Damfu, N; Alnefaie, A; Alqurashi, A; Althagafi, S; Alotaibi, A; Alotaibi, M; Alsuwat, A
    OCT 2024 | PHARMACY 12 (5)

17. Evaluating the Efficiency and Staff Satisfaction of the Point-of-Care IV Activated System Versus Traditional Piggyback in Administering IV Antibiotics at a Saudi Tertiary Hospital
    Elshammaa, K; Yousif, AA; Alshammari, A; Alnuhait, M; Alotaibi, AS; Elrggal, ME; Elnaem, MH
    OCT 2024 | PHARMACY 12 (5)

18. Macrolide resistance outcomes after the Covid-19 pandemic: A one health approach investigation
    Rodrigues, SO; Santiago, FR; Silva, MS; Lima, ASG; Godoy, LE; De Waard, M; Fouad, D; Batiha, GE; Santos, TL; Pagnossa, JP
    NOV 2024 | BIOMEDICINE & PHARMACOTHERAPY 180

19. Pharmacies and use of antibiotics: a cross sectional study in 19 Arab countries
    Hafez, H; Rakab, MS; Elshehaby, A; Gebreel, AI; Hany, M; BaniAmer, M; Sajed, M; Yunis, S; Mahmoud, S; Hamed, M; Abdellatif, M; Alomari, AN; …; Saeed, M
    SEP 18 2024 | ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL 13 (1)

20. Genomic insights into epidemic plasmids carrying blaCTX-M and mcr-1 genes in Escherichia coli from Lebanese broiler production
    Mikhayel, M; Praud, K; Leclercq, S; Sarkis, DK; Doublet, B
    SEP 18 2024 | JAC-ANTIMICROBIAL RESISTANCE 6 (5)

21. Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22
    Wise, MG; DeRyke, CA; Alekseeva, I; Siddiqui, F; Young, K; Motyl, MR; Sahm, DF
    SEP 17 2024 | JAC-ANTIMICROBIAL RESISTANCE 6 (5)

22. Restoring vancomycin activity against resistant Enterococcus faecalis using a transcription factor decoy as a vanA operon-inhibitor
    Abdelall, LM; Nagy, YI; Kashef, MT
    SEP 10 2024 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

23. Characteristics and outcomes of urinary tract infections caused by Enterococci: A multicenter retrospective study from two tertiary hospitals in Saudi Arabia
    Alharthi, KF; Baotob, SM; Bankhar, AM; Alsehli, AA; Idris, IA; Badawood, MS; Alharbi, WK; Almatrafi, MM; Mahrous, AJ; Thabit, AK
    NOV 2024 | JOURNAL OF INFECTION AND CHEMOTHERAPY 30 (11) pp: 1190-1193

24. In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii
    Hessami, A; Mogharari, Z; Rahim, F; Khalesi, B; Nassrullah, OJ; Rahbar, MR; Khalili, S; Jahangiri, A
    DEC 5 2024 | INTERNATIONAL IMMUNOPHARMACOLOGY 142

25. Clopidogrel protects against gentamicin-induced nephrotoxicity through targeting oxidative stress, apoptosis, and coagulation pathways
    Akila, AA; Gad, RA; Ewees, MGE; Abdul-Hamid, M; Abdel-Reheim, ES
    SEP 5 2024 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

26. Generation of empty cell envelopes of Streptococcus pyogenes using biosurfactants
    Abdelfattah, A; Amin, HM; Rabea, S; Samir, R
    SEP 3 2024 | FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES 10 (1)

27. Genomic Characterization of Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Implicated in Bloodstream Infections, KwaZulu-Natal, South Africa: A Pilot Study
    Hetsa, BA; Asante, J; Mbanga, J; Ismail, A; Abia, ALK; Amoako, DG; Essack, SY
    SEP 2024 | ANTIBIOTICS-BASEL 13 (9)

28. Droplet Digital PCR for Acinetobacter baumannii Diagnosis in Bronchoalveolar Lavage Samples from Patients with Ventilator-Associated Pneumonia
    Moreira, MG; Oliveira, AGG; Ul Haq, I; de Oliveira, TFP; Alonazi, WB; Fonseca, AA Jr; Nobre, VA Jr; dos Santos, SG
    SEP 2024 | ANTIBIOTICS-BASEL 13 (9)

29. Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review
    Fatima, N; Khalid, S; Rasool, N; Imran, M; Parveen, B; Kanwal, A; Irimie, M; Ciurea, CI
    SEP 2024 | PHARMACEUTICALS 17 (9)

30. The Appropriateness of Empirical Uses of Antibiotics Based on Antimicrobial Susceptibility Results for Inpatients at a Tertiary Hospital in Saudi Arabia
    Almogbel, Y; Mobark, MA; Almutairi, MS; Almogbel, FS; Rabbani, SI; Alhathloul, S; Alamro, S; Alatallah, L
    SEP 2024 | ANTIBIOTICS-BASEL 13 (9)

مقالات ذات صلة

مستخلص جديد من البكتيريا يمكنه القضاء على البكتيريا المقاومة للمضادات الحيوية

كيف تحمي الإشريكية القولونية نفسها من المضادات الحيوية؟